Stockreport

Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice

Daxor Corporation - Closed End Fund  (DXR) 
NASDAQ:AMEX Investor Relations: daxor.com/investors
PDF NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operation [Read more]